Patients that used marijuana less than 24 hours from their eye exam were significantly more likely to know that marijuana decreases intraocular pressure (p=0.02), highlighting that informed users may be self-medicating in ways that directly confound clinical measurements.
Artelo Biosciences Expands into Glaucoma Market with New Study – Intellectia AI
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic GlaucomaIntraocular PressureOphthalmologyClinical ResearchNeuroprotection Why This MattersGlaucoma represents one of the most promising therapeutic...
Artelo Biosciences stock surges on glaucoma study agreement – Investing.com
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologySafety Why This Matters Clinicians managing glaucoma patients need to monitor emerging cannabinoid therapies as...